157 related articles for article (PubMed ID: 28483342)
1. The Influence of Sex on Prognosis of Patients With Idiopathic Pulmonary Fibrosis in a Retrospective Cohort.
Caro FM; Alberti ML; Fernández ME; Paulin F
Arch Bronconeumol; 2017 Nov; 53(11):649-650. PubMed ID: 28483342
[No Abstract] [Full Text] [Related]
2. Pirfenidone treatment in idiopathic pulmonary fibrosis: too much of a great expectation?
Papiris SA; Kagouridis K; Kolilekas L; Triantafillidou C; Tsangaris I; Manali ED
Eur Respir J; 2012 Sep; 40(3):794-5. PubMed ID: 22941551
[No Abstract] [Full Text] [Related]
3. The prognostic role of Gender-Age-Physiology system in idiopathic pulmonary fibrosis patients treated with pirfenidone.
Harari S; Caminati A; Confalonieri M; Poletti V; Vancheri C; Pesci A; Rogliani P; Luppi F; Agostini C; Rottoli P; Sanduzzi Zamparelli A; Sebastiani A; Della Porta R; Salton F; Messore B; Tomassetti S; Rosso R; Biffi A; Puxeddu E; Cerri S; Cinetto F; Refini RM; Bocchino M; Di Michele L; Specchia C; Albera C;
Clin Respir J; 2019 Mar; 13(3):166-173. PubMed ID: 30675755
[TBL] [Abstract][Full Text] [Related]
4. [Diagnostic criteria and possible treatment of idiopathic pulmonary fibrosis].
Bendstrup E; Hyldgaard C; Hilberg O
Ugeskr Laeger; 2014 Apr; 176(18):. PubMed ID: 25351567
[TBL] [Abstract][Full Text] [Related]
5. Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials.
Noble PW; Albera C; Bradford WZ; Costabel U; Glassberg MK; Kardatzke D; King TE; Lancaster L; Sahn SA; Szwarcberg J; Valeyre D; du Bois RM;
Lancet; 2011 May; 377(9779):1760-9. PubMed ID: 21571362
[TBL] [Abstract][Full Text] [Related]
6. Is pirfenidone effective for idiopathic pulmonary fibrosis?
Jeldres A; Labarca G
Medwave; 2017 Jan; 17(Suppl1):e6843. PubMed ID: 28112713
[TBL] [Abstract][Full Text] [Related]
7. A combined therapeutic approach in progressive idiopathic pulmonary fibrosis-pirfenidone as bridge therapy for ex vivo lung transplantation: a case report.
Paone G; Sebastiani A; Ialleni E; Diso D; Rose D; Quagliarini F; Ialongo P; Peruzzi M; Venuta F; Frati G
Transplant Proc; 2015 Apr; 47(3):855-7. PubMed ID: 25891747
[TBL] [Abstract][Full Text] [Related]
8. Pirfenidone Initiates a New Era in the Treatment of Idiopathic Pulmonary Fibrosis.
Selvaggio AS; Noble PW
Annu Rev Med; 2016; 67():487-95. PubMed ID: 26565677
[TBL] [Abstract][Full Text] [Related]
9. Intraindividual response to treatment with pirfenidone in idiopathic pulmonary fibrosis.
Loeh B; Drakopanagiotakis F; Bandelli GP; von der Beck D; Tello S; Cordani E; Rizza E; Barrocu L; Markart P; Seeger W; Guenther A; Albera C
Am J Respir Crit Care Med; 2015 Jan; 191(1):110-3. PubMed ID: 25551350
[No Abstract] [Full Text] [Related]
10. Forced vital capacity in idiopathic pulmonary fibrosis--FDA review of pirfenidone and nintedanib.
Karimi-Shah BA; Chowdhury BA
N Engl J Med; 2015 Mar; 372(13):1189-91. PubMed ID: 25806913
[No Abstract] [Full Text] [Related]
11. Pharmacological therapy does not contribute to survival in idiopathic pulmonary fibrosis.
Ishii H; Kushima H; Komiya K; Mizunoe S; Kadota J
Respiration; 2013; 86(1):86-7. PubMed ID: 23594834
[No Abstract] [Full Text] [Related]
12. Idiopathic pulmonary fibrosis and pirfenidone.
Collard HR
Eur Respir J; 2010 Apr; 35(4):728-9. PubMed ID: 20356985
[No Abstract] [Full Text] [Related]
13. [Antifibrotic treatment].
von der Beck D; Löh B; Drakopanagiotakis F; Markart P; Günther A
Dtsch Med Wochenschr; 2014 Dec; 139(49):2523-5. PubMed ID: 25423462
[No Abstract] [Full Text] [Related]
14. Treating idiopathic pulmonary fibrosis: current opportunities and future challenges.
Richeldi L
Clin Respir J; 2012 Jul; 6(3):129-30. PubMed ID: 22697263
[No Abstract] [Full Text] [Related]
15. Pirfenidone-Induced Sarcoid-Like Reaction: A Novel Complication.
Kolaitis NA; Kukreja J; Jones KD; Hays SR; Leard LE
Chest; 2018 Oct; 154(4):e89-e92. PubMed ID: 30290953
[TBL] [Abstract][Full Text] [Related]
16. Effect of Perioperative Pirfenidone Treatment in Lung Cancer Patients With Idiopathic Pulmonary Fibrosis.
Iwata T; Yoshida S; Fujiwara T; Wada H; Nakajima T; Suzuki H; Yoshino I
Ann Thorac Surg; 2016 Dec; 102(6):1905-1910. PubMed ID: 27546601
[TBL] [Abstract][Full Text] [Related]
17. Predictors of the clinical effects of pirfenidone on idiopathic pulmonary fibrosis.
Arai T; Inoue Y; Sasaki Y; Tachibana K; Nakao K; Sugimoto C; Okuma T; Akira M; Kitaichi M; Hayashi S
Respir Investig; 2014 Mar; 52(2):136-43. PubMed ID: 24636270
[TBL] [Abstract][Full Text] [Related]
18. Novel treatments for idiopathic pulmonary fibrosis.
Spagnolo P
Am J Med; 2015 May; 128(5):447-9. PubMed ID: 25613299
[No Abstract] [Full Text] [Related]
19. Hot off the breath: A big step forward for idiopathic pulmonary fibrosis.
Ryerson CJ; Collard HR
Thorax; 2014 Sep; 69(9):791-2. PubMed ID: 24996636
[No Abstract] [Full Text] [Related]
20. Therapeutic advances in idiopathic pulmonary fibrosis.
George G; Vaid U; Summer R
Clin Pharmacol Ther; 2016 Jan; 99(1):30-2. PubMed ID: 26502087
[No Abstract] [Full Text] [Related]
[Next] [New Search]
